JANUARY, 2012
The Spanish Human Genetics Association has opened applications for the "Year 2012 Young Investigator Awards". On this occasion, the award is sponsored by the companies Nimgenetics and IZASA. The objective of this award is to highlight the career of a young researcher in the fields of human genetics. The 2012 award carries an stipend of 2000 €. The selection process will take place accordingly to the published award requisites in this link.
NOVEMBER, 2011
Nimgenetics along with the other 19 startups (SME) with the highest growth potential in Spain have visited the largest technological companies in Silicon Valley, California. This visit is part of the "Entrepreneur XX1" award from la Caixa and ENISA.
These 20 startups will have an intense visiting program including exclusive interviews with key businessmen in the high-tech fields, investors, VC, lawyers, etc. This unique ecosystem makes of Silicon Valley the most exciting place on earth for entrepreneurs.
The objective of this initiative is to research potential markets and commercial opportunities, and get to know a different and unique business atmosphere. The 20 spanish SMEs will have a series of meetings with executives from high profile companies in their fields (nano, software, biotech etc), product diustributors, and possible investors that could facilitate the opening of business branch in the USA or even to establish strategic alliances. Moreover, the Spanish SMEs will have the chance of visiting emblematic tech companies such as Google, Pfizer, Agilent Technologies, and paradigmatic institutions like Standford University , the Standford Research Institute (SRI) and the San Jose Biocenter. Read more.
JULY, 2011
Last July, NIMGenetics moved its offices and laboratory to the new installations of the Parque Científico de Madrid located in Nr. 7 of Faraday St., in Cantoblanco, Madrid. This new installations are equipped with the most state of the art technology, that will let NIMGenetics to keep the highest quality standards for genetic diagnosis and genomic research.
JUNE, 2011
NIMGenetics has been described as the best “young” biotech company in 2011, in the blog Madri+d for technological based entrepreneurs. Read more.
APRIL, 2011
In 2011, NIMGenetics has became the first laboratory of Genetic Diagnosis that obtained the Certified Services Provider (CSP) accreditation from Agilent Technologies, for genomic analysis, based on array-CGH. NIMGenetics is right now the only Spanish company with such accreditation. Based on this, NIMGenetics is now a official reference center in Spain and Portugal for the use of Agilent Technologies oligos in array-CGH.
FEB, 2011
Tiu et al. in a recent paper published in the magazine Blood (February 2011), demonstrate that the arrays alone, or in combination with conventional karyotyping, can impact outcome prediction and improve the prognostic stratification in patients with various types of hematologic malignancies. The report demonstrates the potential of novel whole genome scanning technologies, in particular SNP-A-based karyotyping, to improve cytogenetic diagnostics of hematologic malignancies such as MDS and provide clinically useful diagnostic and prognostic information that cannot be obtained with currently used traditional technologies.
Based on our data, we recommend the concurrent use of SNP-A and MC in the initial karyotypic evaluation of patients with hematologic conditions whereby cytogenetics has a clear role in the prognosis of patients, particularly in MDS, MDS/MPN and AML. (Download complete article)
Laurent et al. have Published in the magazine Cell (January 2011) results illustrating the dynamic nature of genomic abnormalities in pluripotent stem cells and the need for frequent genomic monitoring to assure phenotypic stability and clinical safety. Aneuploidies can be detected( by karyotyping, but less easily detectable subchromosomal genetic changes may also have adverse effects. Small abnormalities need to be detected by using comparative genomic hybridization (CGH) and single-nucleotide polymorphism (SNP) genotyping. (Download complete article)
APRIL, 2010
In 2011, NIMGenetics has became the first laboratory of Genetic Diagnosis that obtained the Certified Services Provider (CSP) accreditation from Agilent Technologies, for genomic analysis, based on array-CGH. NIMGenetics is right now the only Spanish company with such accreditation. Based on this, NIMGenetics is now a official reference center in Spain and Portugal for the use of Agilent Technologies oligos in array-CGH
DEC, 2010
NIMGenetics got the prize to the “Best Growing Project for a small Company” in the 9th Edition of the Contest Proyecto Escuela Banespyme-Orange, organized by IE Business School, Banesto Foundation and Orange. PRESS RELEASE (PDF): Cotizalia_1, Cotizalia_2, EFE, El Confidencial, El Economista, Europa Press, Expansion, Globedia, Invertia_1, Invertia_2, La Información, La Voz Libre, RRHH Digital, Siglo XXI, Speaking People, Yahoo! Noticias
OCT, 2010
The Project Banespyme Orange is a contest that provides entrepreneurs, small companies and social projects the required tools of training and planning to analyze the viability of their projects, and if the analysis is positive, Banespyme Orange will support the start up of the winner projects. 20 projects applied initially, and only 10 were selected for the second stage of the contest, in which they will get training on presentation and negotiation techniques, before a meeting with a group of investors. NIMGenetics is among these 10 selected projects. This second stage will start October 22nd and will finish on November 17th. From this 10 projects will be selected the winner for each category: “Best growth project for small companies”, “Best entrepreneurs project” and “Best social project” http://www.banespymeorange.org/seleccionados.do
OCT, 2010
According to the American College of Medical Genetics, Microarrays should be used instead of G-banded karyotyping as the first test to detect genetic abnormalities in postnatal evaluations. (download PDF)
SEPT, 2010
NIMGenetics takes part in the elaboration of the genetic profile of a type
of lymphomas by using arrayCGH. http://www.ncbi.nlm.nih.gov/pubmed/20844552
MAY, 2010
20 projects in the areas of medical care, biotechnology, motility, e-commerce, energetic sustainability and spare time industry, were the finalists to take part in the IX Edition of the Contest for entrepreneurs “Banespyme Orange” organized by the Banesto Foundation, Orange and IE Business School.
In the category "Best growth project for small companies", NIMGenetics was one of the selected companies. http://www.adslnet.es/index.php/2010/05/26/un-total-de-once-emprendedores-si
APRIL, 2010
NIMGenetics, in collaboration with the Departments of Genetics and Oncology of the Hospital Sant Pau (Barcelona), has participated in the study of the influence of copy number variations of genomic regions as modifiers of the phenotype of breast cancer in a pair of identical twins (download PDF)
JULY, 2009
NIMGenetics took part in the round table “Keys for the growth of innovative companies” during the Second General Conference of Competitiveness in the Vasque Country (Bilbao, July, 2nd, 2009). http://www.orkestra.deusto.es/ms/p/73
JUNE, 2009
NIMGenetics in the Spanish Association of Human Genetics (AEGH) Meeting, 2009. NIMGenetics took part in the XXV Meeting of the AEGH (June, 17-19, Santiago de Compostela, Spain). Javier Suela, Technical Director of the company, was an invited speaker in the “satellite session” organized by Agilent Technologies, with the talk: “Applications of aCGH in clinical genetics”
MAY, 2009
NIMGenetics was present in the “Entrepreneur’s Day, 2009” organized by the Comunidad Autónoma de Madrid, participating in the round table “Bio Entrepreneurs” in the Economy School of the University of Alcalá de Henares (Madrid), on May, 26th.
